ESMO 2024
Sep 19, 2024•22 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Recapping just some of the notable data coming out of ESMO 2024:
-Final OS results from Keynote-522 (perioperative pembrolizumab in TNBC)
-AMBASSADOR (adjuvant pembrolizumab in bladder cancer)
-NIAGRA (perioperative durvalumab in bladder cancer)
-ADRIATIC (discussed on ASCO recap Pod, but publication now available)
-LEANOX (impact of lean body mass adjustment on oxaliplatin dose)
For the best experience, listen in Metacast app for iOS or Android